What happens when a rare disease drug seems to work, but the health care system doesn’t?
Cristina Brennan can hear the clock ticking. At the end of the year, her 12-year-old son Tristan will no longer have free access to a pricey medicine that
Cristina Brennan can hear the clock ticking. At the end of the year, her 12-year-old son Tristan will no longer have free access to a pricey medicine that
In a Phase 1 study, nine people with advanced kidney cancer became cancer free after receiving personalized vaccines.
Yale assistant professor of pediatrics Meredithe McNamara talks with STAT about how institutions have responded to Trump’s executive order on gender-affirming care, one week later.
The MAHA era has begun. But to execute his promises on health, RFK Jr. faces tough challenges on vaccines, chronic disease, and big business.
Oliver Sartor interviews Chuck Conroy about Nucleus RadioPharma’s role in radiopharmaceutical manufacturing and distribution. Mr. Conroy explains that Nucleus RadioPharma aims to support both small…
Pfizer has a big problem. The drug giant hopes that new drugs to treat cancer are the solution.
Unlike most previous OSTP directors, Michael Kratsios is not an esteemed scientist or engineer, but he has earned mostly positive reviews.
The USDA said four Nevada dairy herds were infected with an H5N1 bird flu strain which has circulated in wild birds, making prospects for containment…
The USDA said four Nevada dairy herds were infected with an H5N1 bird flu strain which has circulated in wild birds, making prospects for containment…
The USDA said four Nevada dairy herds were infected with an H5N1 bird flu strain which has circulated in wild birds, making prospects for containment…
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. Let’s get…